Int. J. Dev. Biol. 55: 801 - 809 (2011)
doi: 10.1387/ijdb.113345jw
© UBC Press

Proteome changes induced by overexpression of the p75 neurotrophin receptor (p75NTR) in breast cancer cells

Jean-Philippe Wilmet1, Christophe Tastet1, Emilie Desruelles1, Nathalie Ziental-Gelus1, Vincent Blanckaert2, Hubert Hondermarck*,1 and Xuefen Le Bourhis1

SUP>1INSERM U 908 "Growth factor signaling in breast cancer cells. Functional proteomics", IFR-147, University of Lille and 2EA-2160 MMS, University of Maine, France.

ABSTRACT In breast cancer cells, the neurotrophin receptor p75NTR acts as a prosurvival factor able to stimulate resistance to apoptosis, but its mechanism of action remains incompletely defined. In this study, we investigated the global proteome modification induced by p75NTR overexpression in breast cancer cells treated by the pro-apoptotic agent tumor necrosis factor (TNF)-related-apoptosis-inducing-ligand (TRAIL). p75NTR was stably overexpressed in the MCF-7 breast cancer cells and the impact of a treatment by TRAIL was investigated in wild type vs. p75NTR overexpressing cells. Proteins were separated in two-dimensional electrophoresis, and regulated spots were detected by computer assisted analysis before identification by MALDI-TOF/TOF mass spectrometry. In the absence of TRAIL treatment, p75NTR did not induce any change in the proteome of breast cancer cells. In contrast, after treatment with TRAIL, fragments of cytokeratin-8, -18 and -19, as well as full length cytokeratin-18, were up-regulated by p75NTR overexpression. Of note, spectrin alpha-chain and the ribosomal protein RPLP0 were induced by TRAIL, independently of p75NTR level. Interestingly, the well known stress-induced protein HSP-27 was less abundant when p75NTR was overexpressed, indicating that p75NTR overexpression reduced TRAIL induced cell stress. These data indicate that overexpression of p75NTR induces proteome modifications in breast cancer cells and provide information on how this receptor contributes in tumor cell resistance to apoptosis.

Keywords:

breast cancer, neurotrophin receptor p75NTR, TRAIL, proteomics

*Corresponding author e-mail: hubert.hondermarck@newcastle.edu.au